Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04592289
Other study ID # COL-3
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 30, 2020
Est. completion date August 2024

Study information

Verified date November 2023
Source N.N. Petrov National Medical Research Center of Oncology
Contact Aleksei Karachun
Phone +79219462123
Email dr.a.karachun@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine if short-term outcomes of rectal resections after full bowel preparation (mechanical bowel preparation plus oral antibiotics) are superior to rectal resections with only mechanical bowel preparation.


Description:

The design involves random allocation of eligible patients to full bowel preparation or only mechanical bowel preparation in 1:1 ratio. After that rectal resection is performed in both groups. Short-term outcomes are assessed in 30 day period after surgery. This is a superiority trial evaluating statistical superiority. Rate of surgical site infection is anticipated to decrease from 12% (data from local registry) to 6%. For power of 80% enrolment of 622 patients is required. The intent-to-treat principle is used for the data analysis.


Recruitment information / eligibility

Status Recruiting
Enrollment 622
Est. completion date August 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - histologically confirmed adenocarcinoma of the rectum or rectosigmoid junction - clinical stage T1-4aN0-2M0-1 (distant metastases must be resectable) - indications for surgical rectal resection - ECOG status 0-2 - At least 18 years of age - Written informed consent Exclusion Criteria: - Medical or psychiatric conditions that compromise the patient's ability to give informed consent or comply with the study protocol - Pregnancy or breast feeding - Medical contraindications for surgical treatment - Any use of antibiotics 30 days prior to inclusion - Functioning stoma - Contraindications for use of MBP or OA drugs or their components - Indications for obstructive resection or abdominoperineal excision - Acute bowel obstruction, bleeding or perforation - Other malignancies not in remission

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Full bowel preparation
MBP+OA
Mechanical bowel preparation only
MBP

Locations

Country Name City State
Russian Federation GBUZ Moscow Clinical Scientific Center named after Loginov MHD Moscow
Russian Federation I.M. Sechenov First Moscow State Medical University, Clinic of Oncology, Radiotherapy and Reconstructive Surgery Moscow
Russian Federation Lomonosov Moscow State University Medical Research and Educational Center Moscow
Russian Federation Ryazan State Clinical Hospital Ryazan
Russian Federation Scientific-Research institute of Oncology named after N.N. Petrov Saint Petersburg
Russian Federation Tomsk Regional Oncology Hospital Tomsk
Russian Federation Volgograd State Medical University, Ministry of Health of Russia Volgograd

Sponsors (1)

Lead Sponsor Collaborator
N.N. Petrov National Medical Research Center of Oncology

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incisional surgical site infection (SSI) rate Rate of incisional SSI in patients after rectal resections 30 days
Secondary Anastomotic leak rate Rate of clinical and/or radiological anastomotic leaks 30 days
Secondary Intraabdominal and or pelvic abscess rate 30 days
Secondary Overall morbidity Rate of patients with any complications after surgery 30 days
Secondary Rate of intraoperative complications Duration of surgical procedure
Secondary Surgery duration in minutes Duration of surgical procedure
Secondary Quality of bowel preparation assessed by surgeon Assessment of bowel preparation quality by surgeon (qualitative scale) Day of surgery
Secondary Bowel preparation compliance Rate of patients in experimental arm undergoing complete bowel preparation according to protocol Day of surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06380101 - Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) N/A
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT04323722 - Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Active, not recruiting NCT01347697 - Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer N/A
Recruiting NCT04495088 - Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer Phase 3
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Not yet recruiting NCT03520088 - PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS N/A
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1
Recruiting NCT04749381 - The Role of TCM on ERAS of Rectal Cancer Patients Phase 2
Enrolling by invitation NCT05028192 - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Recruiting NCT03283540 - Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
Completed NCT04534309 - Behavioral Weight Loss Program for Cancer Survivors in Maryland N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Recruiting NCT04852653 - A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Terminated NCT02933944 - Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer Phase 1